412317-95-4

Basic information

• Product Name: (2R,3S)-N-(4-azidobenzyloxycarbonyl) phenylisoserine
• Synonyms: (2R,3S)-N-(4-azidobenzyloxycarbonyl) phenylisoserine
• CAS NO: 412317-95-4
• Molecular Weight: 370.365
• Mol File: 412317-95-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2R,3S)-N-(4-azidobenzyloxycarbonyl) phenylisoserine(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-N-(4-azidobenzyloxycarbonyl) phenylisoserine(412317-95-4)
• EPA Substance Registry System: (2R,3S)-N-(4-azidobenzyloxycarbonyl) phenylisoserine(412317-95-4)

Safety Data

• Hazardous Substances Data: 412317-95-4(Hazardous Substances Data)

Upstream product

• 31499-54-4 4-azidobenzyl alcohol 
• 157240-36-3 (2R,3S)-3-phenylisoserine methyl ester 
• 161536-59-0 (4-azidophenyl)methyl 4-nitrophenoxyformate 

Downstream Products

• 412317-93-2 3'N-(4-azidobenzyloxycarbonyl)-3'-N-debenzoylpaclitaxel 
• 412317-96-5 (2S,4S,5R)-2-(4-Methoxy-phenyl)-4-phenyl-oxazolidine-3,5-dicarboxylic acid 3-(4-azido-benzyl) ester 
• 412317-97-6 (2S,4S,5R)-2-(4-Methoxy-phenyl)-4-phenyl-oxazolidine-3,5-dicarboxylic acid 3-(4-azido-benzyl) ester 5-methyl ester 

Relevant articles and documents

Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue

The syntheses and preliminary evaluation of the first potential bioreductive paclitaxel prodrugs are described. These prodrugs were designed as potential candidates in more selective chemotherapy by targeting hypoxic tumour tissue. Aromatic nitro and azid